FBN1 Gene Weill-Marchesani Syndrome Dominant Type 2 Genetic Test
Welcome to DNA Labs UAE, where we offer the FBN1 Gene Weill-Marchesani Syndrome Dominant Type 2 Genetic Test. This test is designed to analyze the FBN1 gene, which is associated with Weill-Marchesani syndrome, specifically the dominant type 2 form.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Dysmorphology
- Doctor: Pediatrics
- Test Department: Genetics
Pre Test Information
Before undergoing the FBN1 Gene Weill-Marchesani Syndrome Dominant Type 2 Genetic Test, it is important to provide the clinical history of the patient who is going for the test. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with the syndrome.
Test Details
Weill-Marchesani syndrome is a rare connective tissue disorder characterized by short stature, joint stiffness, and various eye abnormalities. The FBN1 gene is specifically associated with the dominant type 2 form of this syndrome.
NGS (Next-Generation Sequencing) Genetic Testing is a technique used to analyze multiple genes simultaneously to identify genetic variations or mutations. In the context of Weill-Marchesani syndrome, NGS Genetic Testing can be used to identify specific mutations or variations in the FBN1 gene that are associated with the dominant type 2 form of the syndrome.
By analyzing the FBN1 gene, NGS Genetic Testing can provide valuable information for diagnosis, prognosis, and genetic counseling. It can help confirm the presence of the FBN1 gene mutation, guide appropriate medical management, and provide information about the likelihood of passing the condition to future generations.
It is important to note that NGS Genetic Testing should be performed by a qualified healthcare professional or genetic counselor, who can interpret the results and provide appropriate recommendations and support.
Test Name | FBN1 Gene Weill-Marchesani syndrome dominant type 2 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Dysmorphology |
Doctor | Pediatrics |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for FBN1 Gene Weill-Marchesani syndrome, dominant type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FBN1 Gene Weill-Marchesani syndrome, dominant type 2 NGS Genetic DNA Test gene FBN1 |
Test Details |
The FBN1 gene is associated with a genetic condition called Weill-Marchesani syndrome, specifically the dominant type 2 form. Weill-Marchesani syndrome is a rare connective tissue disorder characterized by short stature, joint stiffness, and various eye abnormalities. NGS (Next-Generation Sequencing) Genetic Testing is a technique used to analyze multiple genes simultaneously to identify genetic variations or mutations. In the context of Weill-Marchesani syndrome, NGS Genetic Testing can be used to identify specific mutations or variations in the FBN1 gene that are associated with the dominant type 2 form of the syndrome. By analyzing the FBN1 gene, NGS Genetic Testing can provide valuable information for diagnosis, prognosis, and genetic counseling. It can help confirm the presence of the FBN1 gene mutation, guide appropriate medical management, and provide information about the likelihood of passing the condition to future generations. It is important to note that NGS Genetic Testing should be performed by a qualified healthcare professional or genetic counselor, who can interpret the results and provide appropriate recommendations and support. |